Prospective, Multicenter Non Interventional Study to Evaluate Adherence to Betaferon Over a 2 Years Period

Launched by BAYER · Feb 25, 2010

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Male or female \>/= 18 years old
• • Outpatient with a confirmed diagnosis of Recurrent-Remittent multiple sclerosis or patients at high risk of developing multiple sclerosis after a first demyelinating clinical event
• • Patient who initiated Betaferon as described by SmPC less than 2 months ago. The decision of physician is clearly separated from the decision to include the patient in the study
• • Treatment naïve patients before the initiation of Betaferon
• • OR Patients having interrupted Betaferon for more than 6 months before to start again
• • OR Patients receiving a disease modifying drug (DMD) other than Betaferon
• • Patient with EDSS score \< 4
• • Patients approved and signed an inform consent and approved the collect of their data
• Exclusion Criteria:
• • Contraindications and warning of the respective Summary of Product Characteristics